United States· US:0074-2600_2c392930-500d-4e9b-93ac-317c4d48251c
Mavyret
A glecaprevir and pibrentasvir product containing pibrentasvir; glecaprevir, registered in United States by AbbVie Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Glecaprevir and pibrentasvir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AP57 (glecaprevir and pibrentasvir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Glecaprevir and pibrentasvir · ATC J05AP57
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PIBRENTASVIR; GLECAPREVIR
- Manufacturer
- AbbVie Inc.
- Country
- United States (US)
- ATC code
- J05AP57
- ATC class
- Glecaprevir and pibrentasvir
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 2, 2026
Packs & prices · 2
- ndc1100742600281 PACKET in 1 CARTON (0074-2600-28) / 28 PELLET in 1 PACKET
- ndc110074-2600-28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glecaprevir and pibrentasvir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGlecaprevir 100mg / Pibrentasvir 40mg tabletsAbbVie Ltd
- SpainMAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAbbvie Deutschland Gmbh & Co. Kg
- FinlandMaviretAbbVie Deutschland GmbH&Co.KG
- FranceMAVIRET 100 mg/40 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- CanadaMAVIRETABBVIE CORPORATION
- IcelandMaviretAbbVie Deutschland GmbH & Co. KG
- NetherlandsMaviret 100 mg/40 mg filmomhulde tablettenAbbVie Deutschland GmbH & Co. KG
- NorwayMaviretAbbVie Deutschland GmbH & Co
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Glecaprevir/Pibrentasvir Abbvie
- Iceland · Maviret
- Liechtenstein · Maviret
- Norway · Maviret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49ef95b0-a9ef-4a54-ad18-94a7c501a20c GET /v1/drugs/49ef95b0-a9ef-4a54-ad18-94a7c501a20c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 20",
"substance": "PIBRENTASVIR; GLECAPREVIR",
"productndc": "0074-2600",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA215110",
"marketing_category": "NDA"
}See everything about glecaprevir and pibrentasvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.